Skip to main content

OTCMKTS:EMHTF - Emerald Health Therapeutics Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$0.19
+0.30 (1.20%)
1 month | 3 months | 12 months
Get New Emerald Health Therapeutics Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for EMHTF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for EMHTF

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Emerald Health Therapeutics in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $0.19.

N/A

The current consensus among 0 investment analysts is to n/a stock in Emerald Health Therapeutics. This rating has held steady since February 2020, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
11/14/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
2/12/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/12/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/10/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/8/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/6/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/7/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/7/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
2/25/2019Jefferies Financial GroupInitiated CoverageHold
i
(Data available from 5/8/2016 forward)
Emerald Health Therapeutics logo
Emerald Health Therapeutics, Inc., together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc. and changed its name to Emerald Health Therapeutics, Inc. in June 2015. Emerald Health Therapeutics, Inc. is headquartered in Vancouver, Canada.
Read More

Today's Range

Now: $0.19
$0.18
$0.20

50 Day Range

MA: $0.22
$0.19
$0.24

52 Week Range

Now: $0.19
$0.11
$0.47

Volume

165,871 shs

Average Volume

585,635 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Emerald Health Therapeutics?

The following equities research analysts have issued reports on Emerald Health Therapeutics in the last year:
View the latest analyst ratings for EMHTF.

What is the current price target for Emerald Health Therapeutics?

0 Wall Street analysts have set twelve-month price targets for Emerald Health Therapeutics in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Emerald Health Therapeutics in the next year.
View the latest price targets for EMHTF.

What is the current consensus analyst rating for Emerald Health Therapeutics?

Emerald Health Therapeutics currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for EMHTF.

What other companies compete with Emerald Health Therapeutics?

How do I contact Emerald Health Therapeutics' investor relations team?

The company's listed phone number is (800) 757-3536. The official website for Emerald Health Therapeutics is www.emerald.care.